查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433306

全球神经血管栓塞器材市场 2023-2030

Global Neurovascular Embolization Devices Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030年），全球神经血管栓塞设备市场将以6.3%的CAGR成长。市场成长归因于脑动脉瘤盛行率的增加以及与颅内动脉瘤相关的严重风险，例如认知功能永久性丧失和神经系统疾病。脑动脉瘤在所有年龄层的个体中同样普遍，但 35 岁及以上的个体风险较高。根据脑动脉瘤基金会 (BAF) 的数据，估计美国有 670 万人患有未破裂的脑动脉瘤，即每 50 人中就有 1 人患有未破裂脑动脉瘤。脑动脉瘤最常见于 35 至 60 岁的族群，但也可能发生在儿童。大多数动脉瘤是在 40 岁之后形成的。女性比男性更容易罹患脑动脉瘤（比例为 3:2）。所有这些因素都迫使製造商推出新颖和尖端的神经血管栓塞设备，并提高全球食品和药物管理局 (FDA) 的许可。例如，2022 年 3 月，Artio Medical, Inc. 是一家为外周血管、神经血管和心臟病学市场开发创新产品的医疗器械公司，其新一代外周血管产品 solus gold 栓塞装置获得美国 FDA 批准。闭塞。

细分市场前景

全球神经血管栓塞设备市场根据产品和最终用途进行细分。根据产品，市场分为栓塞弹簧圈和分流装置。此外，根据最终用途，市场分为医院和专科诊所。在最终用途中，医院细分市场预计将占据相当大的市场份额，因为它易于获得，提供灵活的调度选项，对生活方式忙碌、寻求快速有效治疗的个人有吸引力。

预计栓塞线圈子细分市场将在全球神经血管栓塞设备市场中占据相当大的份额

在这些产品中，栓塞线圈子细分市场预计将在全球神经血管栓塞设备市场中占据相当大的份额，因为它可以治疗以前被认为无法手术的脑动脉瘤。根据博蒙特健康系统发表的研究，小颈小动脉瘤的弹簧圈栓塞比宽颈大或巨大动脉瘤的栓塞效果更好。长期追踪显示，超过 80% 的动脉瘤经弹簧圈栓塞治疗取得了永久性成功。行业市场参与者开发的用于治疗神经系统疾病的产品的进步推动了市场的成长。例如，2023 年 7 月，波士顿科学公司推出了用于微创週边栓塞手术的 Embold 软线圈和填充线圈。同样，2023 年 6 月，美国 FDA 批准了线圈。 Embold 线圈包含一个输送机构，使用户可以轻鬆拆卸线圈。

区域展望

全球神经血管栓塞器械市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，亚太地区预计将在全球市场中占据显着份额，因为人口老化加剧、神经系统疾病以及新兴经济体可支配收入的增加正在推动亚太地区的市场成长。

北美地区预计全球神经血管栓塞器材市场复合CAGR显着成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。支持该区域市场成长的主要因素包括人口老化的加剧，脑动脉瘤、颈动脉狭窄和中风等神经血管疾病发病率的增加，这增加了北美对神经血管栓塞设备的需求。根据美国疾病管制与预防中心 (CDC) 的数据，到 2022 年，美国每年有超过 795,000 人中风。其中约 61 万例为首次或新中风。约 185,000 例中风患者中，近四分之一的人曾经中风。大约 87.0% 的中风是缺血性中风，即流向大脑的血液受阻。美国每 40 秒就有一人中风。每 3 分 14 秒就有一人死于中风。

市场参与者展望

服务全球神经血管栓塞设备市场的主要公司包括 B. Braun Melsungen AG、Cerenovus Inc.、Medtronic plc、Stryker Corp. 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2023年1月，Fluidx Medical Technology, Inc.在与脑膜中动脉（MMA）栓塞相关的体内研究中发布了IMPASS栓塞装置，可用于治疗大脑表面的慢性硬膜下血肿（CSDH） 。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球神经血管栓塞器械市场的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • B. Braun Melsungen AG
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Cerenovus Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Medtronic plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Stryker Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 全球神经血管栓塞设备市场（按产品）
    • 栓塞弹簧圈
    • 分流装置
  • 全球神经血管栓塞器械市场（依最终用途）
    • 医院
    • 专科诊所

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Acandis GmbH
  • Balt Extrusion SA
  • Boston Scientific Corp.
  • DePuy Synthes (Johnson & Johnson Services, Inc.)
  • Integra Lifesciences Holdings Corp.
  • MicroVention Inc.
  • Penumbra Inc.
  • Phenox GmbH
  • Resonetics LLC
  • Spartan Micro, Inc.
  • Terumo Medical Corp.
Product Code: OMR2027923

Global Neurovascular Embolization Devices Market Size, Share & Trends Analysis Report by Product (Embolic Coils and Flow Diversion Devices), and by End-Use (Hospitals and Specialty Clinics), Forecast Period (2023-2030)

The global neurovascular embolization devices market is anticipated to grow at a CAGR of 6.3% during the forecast period (2023-2030). The market growth is attributed to the increasing prevalence of cerebral aneurysms, and severe risks associated with intracranial aneurysms, such as permanent loss of cognitive functions and neurological disorders. Brain aneurysm is equally prevalent in individuals of all age groups, however individuals 35 years and above are at high risk. According to the Brain Aneurysm Foundation (BAF), an estimated 6.7 million people in the US have an unruptured brain aneurysm or 1 in 50 people. Brain aneurysms are most prevalent in people aged between 35 to 60 years, however it may occur in children as well. Most aneurysms is developed after the age of 40 years. Women are more likely than men to have a brain aneurysm (3:2 ratio). All these factors have compelled manufacturers to introduce novel and cutting-edge neurovascular embolization devices and rising Food and Drug Administration (FDA) clearance globally. For instance, in March 2022, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, received US FDA clearance for its solus gold embolization device, a next-generation product for peripheral vascular occlusion.

Segmental Outlook

The global neurovascular embolization devices market is segmented on the product, and end-use. Based on the product, the market is sub-segmented into embolic coils and flow diversion devices. Further, based on end-use, the market is sub-segmented into hospitals and specialty clinics. Among the end-use, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the easy availability, offer flexible scheduling options, appealing to individuals with busy lifestyles who are seeking quick and effective treatments.

Embolic Coils Sub-Segment is Anticipated to Hold a Considerable Share of the Global Neurovascular embolization devices Market

Among the products, the embolic coils sub-segment is expected to hold a considerable share of the global neurovascular embolization devices market, owing to the allowing treatment of cerebral aneurysms that previously were considered inoperable. As per the study published by Beaumont Health System, coil embolization of small aneurysms with small neck has better results than embolization of large or giant aneurysm with wide necks. Long term follow up has shown permanent success in more than 80% of aneurysms treated with coil embolization. The advancements in the products designed for the treatment of neurological disorders developed by the industry market players drive the growth of the market. For instance, in July 2023, Boston Scientific Corp., launched its Embold soft and packing coils for minimally invasive peripheral embolization procedures. Similarly, in June 2023, the US FDA cleared the coils. Embold coils contain a delivery mechanism that allows users to detach the coil easily.

Regional Outlook

The global neurovascular embolization devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market around the globe, owing to the growing aging population, neurological disorders, and the rising disposable income in emerging economies are driving the market growth in the Asia-Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Neurovascular Embolization Devices Market

Among all the regions, the North America region is anticipated to grow at a considerable CAGR over the forecast period. The primary factor supporting the regional market growth includes the growing the aging population, increasing incidence of neurovascular diseases such as brain aneurysm, carotid stenosis, and stroke, which increases the requirement of neurovascular embolization devices in Noth America. According to the Centers for Disease Control and Prevention (CDC), in 2022, yearly more than 795,000 people in the US encountered with a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes nearly 1 in 4 are in people who have had a previous stroke. About 87.0% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. Every 40 seconds, someone in the US has a stroke. Every 3 minutes and 14 seconds, someone dies of a stroke.

Market Players Outlook

The major companies serving the global neurovascular embolization devices market include B. Braun Melsungen AG, Cerenovus Inc., Medtronic plc, Stryker Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, Fluidx Medical Technology, Inc. released the IMPASS Embolic Device in in-vivo research related to middle meningeal artery (MMA) embolization which can be used to treat chronic subdural hematomas (CSDH) on the surface of the brain.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global neurovascular embolization devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. B. Braun Melsungen AG
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Cerenovus Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Medtronic plc
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Stryker Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Neurovascular Embolization Devices Market by Product
    • 4.1.1. Embolic Coils
    • 4.1.2. Flow Diversion Devices
  • 4.2. Global Neurovascular Embolization Devices Market by End-Use
    • 4.2.1. Hospitals
    • 4.2.2. Specialty Clinics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Acandis GmbH
  • 6.2. Balt Extrusion SA
  • 6.3. Boston Scientific Corp.
  • 6.4. DePuy Synthes (Johnson & Johnson Services, Inc.)
  • 6.5. Integra Lifesciences Holdings Corp.
  • 6.6. MicroVention Inc.
  • 6.7. Penumbra Inc.
  • 6.8. Phenox GmbH
  • 6.9. Resonetics LLC
  • 6.10. Spartan Micro, Inc.
  • 6.11. Terumo Medical Corp.

LIST OF TABLES

  • 1. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL NEUROVASCULAR EMBOLIC COILS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL FLOW DIVERSION NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 5. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR SPECIALTY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 9. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 11. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 13. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 14. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 17. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL NEUROVASCULAR EMBOLIC COILS MARKET SHARE, 2022 VS 2030 (%)
  • 3. GLOBAL FLOW DIVERSION NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022 VS 2030 (%)
  • 5. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR SPECIALTY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. US NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 9. CANADA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 10. UK NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. FRANCE NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. GERMANY NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. ITALY NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. SPAIN NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. REST OF EUROPE NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. INDIA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CHINA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. JAPAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SOUTH KOREA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)